Literature DB >> 26684629

CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.

Necil Kutukculer1, Elif Azarsiz2, Guzide Aksu1, Neslihan Edeer Karaca1.   

Abstract

Common variable immunodeficiency (CVID) is a heterogeneous group of primary antibody deficiencies characterized by decreased serum immunoglobulin G along with a decrease in serum IgA and/or IgM, defective specific antibody production, and recurrent bacterial infections. Abnormal lymphocyte trafficking, dysregulated cellular responses to chemokines, and uncontrolled T cell polarization may be involved in the pathogenesis and may help to understand the clinical complications. We evaluated T helper cell subsets (chemokine receptors CCR4, CCR5, and CCR7), expressions on T lymphocytes, intracellular cytokines - IL-2, IL-4, IL-13, IFN- γ-on CD4(+) T cells, and expression of CD4(+)CD25(+)Foxp3(+) regulatory T cells of 20 CVID patients and 26 healthy controls. Autoimmune clinical findings and other complications were also determined. Percentages and absolute numbers of CD4(+)CD25(+) Foxp3(+) cells did not show any significant difference between CVID cases and healthy controls nor between severe and moderate disease patients. The only significant difference regarding Th1 and Th2 type intracellular cytokines was the decreased absolute numbers of CD3(+)CD4(+)IL4(+) cells in CVID cases. There were some findings about T helper cell type dominance in CVID patients such as positive correlation between hepatomegaly and high IL-2 and IFN-γ in CD3(+)CD4(+) cells and very high expression of CCR5 (Th1) on CD3(+)CD4(+) cells in patients with granuloma. Th1 (CCR5) and Th2 (CCR4) type chemokine receptors did not show any dominance in CVID cases. However, frequencies of CCR7 expressing CD3(+) T cells, CD3(+)CD4(+) T helper cells and CD3(+)CD8(+) T cytotoxic cells were significantly lower in severe CVID patients. In addition, presence of autoimmune clinical findings was negatively correlated with CCR7(+) cells. As CCR7 is a key mediator balancing immunity and tolerance in the immune system, the abnormality of this mediator may contribute to the profound immune dysregulation seen in CVID. In addition, Th1 cells seem to be more involved in the disease pathogenesis than Th2 cells.
© The Author(s) 2015.

Entities:  

Keywords:  CVID; Th1/Th2 chemokine receptors; Treg cells; intracellular cytokines

Mesh:

Substances:

Year:  2015        PMID: 26684629      PMCID: PMC5806726          DOI: 10.1177/0394632015617064

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  37 in total

1.  Guidelines for the presentation of flow cytometric data.

Authors:  Mario Roederer; Zbigniew Darzynkiewicz; David R Parks
Journal:  Methods Cell Biol       Date:  2004       Impact factor: 1.441

Review 2.  Chemokines: signal lamps for trafficking of T and B cells for development and effector function.

Authors:  C H Kim; H E Broxmeyer
Journal:  J Leukoc Biol       Date:  1999-01       Impact factor: 4.962

3.  Frequency and expression of inhibitory markers of CD4(+) CD25(+) FOXP3(+) regulatory T cells in patients with common variable immunodeficiency.

Authors:  N Arandi; A Mirshafiey; H Abolhassani; M Jeddi-Tehrani; R Edalat; B Sadeghi; M Shaghaghi; A Aghamohammadi
Journal:  Scand J Immunol       Date:  2013-05       Impact factor: 3.487

Review 4.  Lymphocyte responses and cytokines.

Authors:  W E Paul; R A Seder
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

Review 5.  Manipulation of the Th1/Th2 balance in autoimmune disease.

Authors:  L B Nicholson; V K Kuchroo
Journal:  Curr Opin Immunol       Date:  1996-12       Impact factor: 7.486

6.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

7.  Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency.

Authors:  Necil Kutukculer; Nesrin Gulez; Neslihan E Karaca; Guzide Aksu; Afig Berdeli
Journal:  J Clin Immunol       Date:  2012-06-15       Impact factor: 8.317

8.  Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors.

Authors:  M Birkenbach; K Josefsen; R Yalamanchili; G Lenoir; E Kieff
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

Review 9.  Autoimmune manifestations in common variable immunodeficiency.

Authors:  C Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2008-03-06       Impact factor: 8.317

10.  A decreased frequency of regulatory T cells in patients with common variable immunodeficiency.

Authors:  Karina M Melo; Karina I Carvalho; Fernanda R Bruno; Lishomwa C Ndhlovu; Wassim M Ballan; Douglas F Nixon; Esper G Kallas; Beatriz T Costa-Carvalho
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more
  13 in total

Review 1.  Common variable immune deficiency: Dissection of the variable.

Authors:  Charlotte Cunningham-Rundles
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 2.  Infectious Complications Reporting in Common Variable Immunodeficiency: A Systematic Review and Meta-analysis.

Authors:  Hamed Zainaldain; Fatema Sadaat Rizvi; Hosein Rafiemanesh; Mahla Alizadeh; Mahnaz Jamee; Sara Mohammadi; Fatemeh Kiaee; Hamed Mohammadi; Farhad Babaie; Reza Yazdani; Hassan Abolhassani; Asghar Aghamohammadi; Gholamreza Azizi
Journal:  Oman Med J       Date:  2020-07-30

3.  The histamine H4 receptor modulates the differentiation process of human monocyte-derived M1 macrophages and the release of CCL4/MIP-1β from fully differentiated M1 macrophages.

Authors:  Susanne Mommert; Lisanne Ratz; Holger Stark; Ralf Gutzmer; Thomas Werfel
Journal:  Inflamm Res       Date:  2018-03-29       Impact factor: 4.575

4.  Combined immunodeficiency (CVID and CD4 lymphopenia) is associated with a high risk of malignancy among adults with primary immune deficiency

Authors:  R Shavit; R Maoz-Segal; S Frizinsky; S Haj-Yahia; I Offengenden; D Machnas-Mayan; Y Tunisky; M Iancovici-Kidon; N Agmon-Levin
Journal:  Clin Exp Immunol       Date:  2021-02-25       Impact factor: 4.330

5.  Reference Values for a Panel of Cytokinergic and Regulatory Lymphocyte Subpopulations.

Authors:  Vincenzo Sorrenti; Bruno Marenda; Stefano Fortinguerra; Claudia Cecchetto; Roberta Quartesan; Giulia Zorzi; Morena Zusso; Pietro Giusti; Alessandro Buriani
Journal:  Immune Netw       Date:  2016-12-22       Impact factor: 6.303

6.  Predominantly Antibody-Deficient Patients With Non-infectious Complications Have Reduced Naive B, Treg, Th17, and Tfh17 Cells.

Authors:  Emily S J Edwards; Julian J Bosco; Pei M Aui; Robert G Stirling; Paul U Cameron; Josh Chatelier; Fiona Hore-Lacy; Robyn E O'Hehir; Menno C van Zelm
Journal:  Front Immunol       Date:  2019-11-15       Impact factor: 7.561

Review 7.  Current Understanding and Recent Developments in Common Variable Immunodeficiency Associated Autoimmunity.

Authors:  Jessica D Gereige; Paul J Maglione
Journal:  Front Immunol       Date:  2019-12-10       Impact factor: 7.561

Review 8.  Primary Humoral Immune Deficiencies: Overlooked Mimickers of Chronic Immune-Mediated Gastrointestinal Diseases in Adults.

Authors:  Ida Judyta Malesza; Michał Malesza; Iwona Krela-Kaźmierczak; Aleksandra Zielińska; Eliana B Souto; Agnieszka Dobrowolska; Piotr Eder
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

9.  Acorus gramineusand and Euodia ruticarpa Steam Distilled Essential Oils Exert Anti-Inflammatory Effects Through Decreasing Th1/Th2 and Pro-/Anti-Inflammatory Cytokine Secretion Ratios In Vitro.

Authors:  Tzu-He Yeh; Jin-Yuarn Lin
Journal:  Biomolecules       Date:  2020-02-19

10.  Non-infectious Complications of Common Variable Immunodeficiency: Updated Clinical Spectrum, Sequelae, and Insights to Pathogenesis.

Authors:  Hsi-En Ho; Charlotte Cunningham-Rundles
Journal:  Front Immunol       Date:  2020-02-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.